$EOS

QUINTON KEITH purchased $107K of EOS

QUINTON KEITH purchased 5,000 shares of Eaton Vance Enhanced Equity Income Fund II (EOS) at $21.39 ($0.11M total) on 2026-08-21.

Original reporting
SEC EDGAR · QUINTON KEITH
Published Aug 21, 2026, 7:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 7:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$EOS
Neutral
high confidence
Mentioned
$EOS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EOSNeutralLow
01

Why it matters

The purchase is modest relative to the fund's size and unlikely to affect market perception.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming portfolio changes not disclosed.

Relevance 5/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider trades; investors watch for signals of insider sentiment.

Company-level read

Ticker impact

$EOSNeutralHigh confidence
Context

Quinton Keith purchased 5,000 shares of EOS for $106,950 on 2026-08-21.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size is modest ($107k) for a fund with large assets, and no change in control is indicated.

Market effects

None; the fund holds diversified equities.

None

None

Counterpoint

Even small insider buys can signal confidence; monitor for follow‑on purchases.

Key entities

  • Quinton Keith

    Reporter of the Form 4 filing.

  • Eaton Vance Enhanced Equity Income Fund II

    Mutual fund with ticker EOS.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EOSMedAI 8/10

Defence Technology Review (Issue 129)

Electro Optic Systems (EOS) says it received a AUD$5.7 million contract under Australia’s ASCA Mission Syracuse to develop and demonstrate a production-ready prototype of its R400 Slinger remote weapon system for counter-drone (C-UAS) use. The prototype will use 70 mm laser-guided rockets and a MAG-58 7.62 mm machine gun, with a December 2027 final demo.

$EOSMed

Electro Optic Systems Shares Surge 12.6% as ASX 200 Inclusion and Defense Boom Fuel Rally

Electro Optic Systems Holdings shares rose 12.63% to $10.52 on Friday, driven by expectations of ASX 200 inclusion on June 22, 2026 and continued order intake momentum, according to the report. The company’s share purchase plan drew AU$95 million of applications versus a $25 million target, with acceptance upsized to $40 million. It reported a contract backlog over AU$518 million and 2026 revenue guidance up to AU$270 million.

$EOSMedAI 8/10

EOS Shares Slide As Guidance Upgrade Overshadowed: The Latest

Electro Optic Systems (ASX:EOS) shares fell 4.5% despite upgraded FY26 guidance and a US$5m contract with L3Harris to integrate its Australian-made counter-drone system for 2026 delivery. EOS expects FY26 base revenue of $240–$270m (vs $128.5m FY25 continuing ops) and plans to invest $10m+ in Nice, France, for MARSS. The stock drop reflected broader defence-sector sentiment.

$EOSMedAI 8/10

EOS Shares Flip Into Reverse, as Rally Takes Pause for Test

Electro Optic Systems (ASX: EOS) reversed after a 55% two-week rally, falling 9.24% to close at A$10.80, with volume at 0.57x average, suggesting profit-taking. The stock had risen from about A$7 to A$11.90. EOS’s May A$190m equity raise and 2025 return to profitability (A$128.5m sales, A$18.6m net income) remain key investor focus.

$EOSMedAI 9/10

EOS Shares Amongst ASX 200 Leaders, Up 15%: The Latest

Electro Optic Systems (ASX:EOS) shares rose 15.08% to A$11.02, helping the stock rank among ASX 200 leaders, after the company appointed two retired Australian Defence Force leaders as non-executive directors effective 1 June 2026, according to an ASX statement. The appointments follow EOS’s ~A$190m capital raising to buy UK’s MARSS for counter-drone and autonomous maritime security, with management citing potential recurring service/software revenue.

$EOSMedAI 8/10

Why EOS, Life360, Nufarm, and Web Travel shares are pushing higher today

The ASX 200 is up 0.1% to 8,667.9 points. Electro Optic Systems (EOS) rose 2.5% to $9.12 after Bell Potter reiterated a buy rating and lifted its target to $10.60. Life360 (360) gained 1.5% to $19.10 on a Bell Potter target upgrade to $33.00. Nufarm (NUF) jumped 14% to $2.92 after half-year results showed revenue down 5% to $1.7b but underlying NPAT up 35% to $52m and reaffirmed FY2026 positive free cash flow.